Abstract
The outbreak of SARS-CoV-2-associated pneumonia, a disease called COVID-19, has caused a pandemic worldwide. To investigate the immune responses after infection of SARS-CoV-2 in non-critical patients may help to better understand the disease progression. We collected 334 confirmed COVID-19 cases including 212 still in hospital with nucleic acid test positive on halfway for SARS-CoV-2 and 122 discharged from hospital, compared specific antibodies, immune cells, and cytokine changes between the hospitalized and discharged patients. The hospitalized patients had a longer illness time compared with discharged patients. Analysis of viral loads explained long-term or persistent infection of SARS-CoV-2, which existed with the median time of 18.5 days of the positive nucleic acid test. Serum analysis showed that the specific anti-N IgG antibody was positive in all detected patients after infection of two weeks. Neutrophils, Monocytes, NK cells, and CD4+ T cells significantly increased, while total lymphocytes and CD8+ T cells decreased from non-critical hospitalized patients after longer-term infection. Further analysis of the cytokines showed that IL-6, TNF-α, IFN-γ, IL-2, IL-4, and IL-10 from the hospitalized patients were significantly higher, indicating a potential of the increased CD4+ T cell differentiation.
Keywords:
Immune response; Long-term infection; SARS-CoV-2.
Copyright © 2020. Published by Elsevier Inc.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aged
-
Antibodies, Viral / blood
-
Betacoronavirus / immunology
-
Betacoronavirus / pathogenicity*
-
COVID-19
-
Cardiovascular Diseases / epidemiology
-
Cardiovascular Diseases / immunology*
-
Cardiovascular Diseases / pathology
-
Cardiovascular Diseases / virology
-
China / epidemiology
-
Comorbidity
-
Convalescence
-
Coronavirus Infections / epidemiology
-
Coronavirus Infections / immunology*
-
Coronavirus Infections / pathology
-
Coronavirus Infections / virology
-
Cytokines / blood
-
Diabetes Mellitus / epidemiology
-
Diabetes Mellitus / immunology*
-
Diabetes Mellitus / pathology
-
Diabetes Mellitus / virology
-
Female
-
Hospitalization
-
Humans
-
Immunity, Innate*
-
Killer Cells, Natural / immunology
-
Killer Cells, Natural / pathology
-
Killer Cells, Natural / virology
-
Lung Diseases / epidemiology
-
Lung Diseases / immunology*
-
Lung Diseases / pathology
-
Lung Diseases / virology
-
Lymphocyte Subsets / immunology
-
Lymphocyte Subsets / pathology
-
Lymphocyte Subsets / virology
-
Male
-
Middle Aged
-
Monocytes / immunology
-
Monocytes / pathology
-
Monocytes / virology
-
Neoplasms / epidemiology
-
Neoplasms / immunology*
-
Neoplasms / pathology
-
Neoplasms / virology
-
Neutrophils / immunology
-
Neutrophils / pathology
-
Neutrophils / virology
-
Pandemics
-
Patient Discharge
-
Pneumonia, Viral / epidemiology
-
Pneumonia, Viral / immunology*
-
Pneumonia, Viral / pathology
-
Pneumonia, Viral / virology
-
SARS-CoV-2
-
Time Factors
-
Viral Load / immunology
Substances
-
Antibodies, Viral
-
Cytokines